These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 29407687)

  • 41. Cue Exposure Triggers Inhibitory Deficits in Individuals With Methamphetamine Use Disorder.
    He X; Zhao D; Zhang M; Leng Y; He W
    J Stud Alcohol Drugs; 2021 Mar; 82(2):197-203. PubMed ID: 33823966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Executive function in methamphetamine users with and without psychosis.
    Koopowitz SM; Cotton SM; Uhlmann A; Thomas KGF; Stein DJ
    Psychiatry Res; 2022 Nov; 317():114820. PubMed ID: 36075151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive functioning in the first-episode of major depressive disorder: A systematic review and meta-analysis.
    Ahern E; Semkovska M
    Neuropsychology; 2017 Jan; 31(1):52-72. PubMed ID: 27732039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding heterogeneity in older adults: Latent growth curve modeling of cognitive functioning.
    MacAulay RK; Calamia MR; Cohen AS; Daigle K; Foil H; Brouillette R; Bruce-Keller AJ; Keller JN
    J Clin Exp Neuropsychol; 2018 Apr; 40(3):292-302. PubMed ID: 28669314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
    Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
    Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women.
    van der Plas EA; Crone EA; van den Wildenberg WP; Tranel D; Bechara A
    J Clin Exp Neuropsychol; 2009 Aug; 31(6):706-19. PubMed ID: 19037812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurocognitive deficits in cocaine users: a quantitative review of the evidence.
    Jovanovski D; Erb S; Zakzanis KK
    J Clin Exp Neuropsychol; 2005 Feb; 27(2):189-204. PubMed ID: 15903150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Social-cognitive difficulties in former users of methamphetamine.
    Henry JD; Mazur M; Rendell PG
    Br J Clin Psychol; 2009 Sep; 48(Pt 3):323-7. PubMed ID: 19397848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis.
    Lim J; Oh IK; Han C; Huh YJ; Jung IK; Patkar AA; Steffens DC; Jang BH
    Int Psychogeriatr; 2013 Sep; 25(9):1543-57. PubMed ID: 23725644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
    Hester R; Lee N; Pennay A; Nielsen S; Ferris J
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):489-97. PubMed ID: 21186923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives.
    Bora E; Yucel M; Pantelis C
    J Affect Disord; 2009 Feb; 113(1-2):1-20. PubMed ID: 18684514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Premorbid adjustment predictors of cognitive dysfunction in schizophrenia.
    Stefanatou P; Karatosidi CS; Tsompanaki E; Kattoulas E; Stefanis NC; Smyrnis N
    Psychiatry Res; 2018 Sep; 267():249-255. PubMed ID: 29940456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use.
    Chen YC; Wang LJ; Lin SK; Chen CK
    Subst Use Misuse; 2015; 50(14):1778-85. PubMed ID: 26625283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Similar profiles of cognitive domain deficits between medication-naïve patients with bipolar II depression and those with major depressive disorder.
    Liu T; Zhong S; Wang B; Liao X; Lai S; Jia Y
    J Affect Disord; 2019 Jan; 243():55-61. PubMed ID: 30227315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency.
    Marquine MJ; Iudicello JE; Morgan EE; Brown GG; Letendre SL; Ellis RJ; Deutsch R; Woods SP; Grant I; Heaton RK;
    Psychiatry Res; 2014 Jan; 215(1):208-16. PubMed ID: 24290100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness.
    Dean AC; Morales AM; Hellemann G; London ED
    Neuropsychopharmacology; 2018 Jul; 43(8):1745-1752. PubMed ID: 29704001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between functional performance and executive cognitive functions in an elderly population including patients with low ankle-brachial index.
    Ferreira NV; Cunha PJ; da Costa DI; dos Santos F; Costa FO; Consolim-Colombo F; Irigoyen MC
    Clin Interv Aging; 2015; 10():839-46. PubMed ID: 26005338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances.
    Pillet B; Morvan Y; Todd A; Franck N; Duboc C; Grosz A; Launay C; Demily C; Gaillard R; Krebs MO; Amado I
    Disabil Rehabil; 2015; 37(10):846-53. PubMed ID: 25109501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis.
    Bo Q; Mao Z; Li X; Wang Z; Wang C; Ma X
    PLoS One; 2017; 12(4):e0176212. PubMed ID: 28437438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.